Company Filing History:
Years Active: 2019
Title: Maxim Ryadnov: Innovator in Cyclic Peptide Technology
Introduction
Maxim Ryadnov is a notable inventor based in Teddington, GB. He has made significant contributions to the field of peptide technology, particularly with his innovative work on cyclic peptides. His research focuses on creating structures that can mimic biological environments, which has important implications for cell growth and biofilm resistance.
Latest Patents
Maxim Ryadnov holds a patent for a cyclic peptide that includes two domains, each comprising three charged sub-domains. The first domain consists of two anionic sub-domains followed by a cationic sub-domain. The second domain features two cationic sub-domains followed by an anionic sub-domain. These domains are interconnected and separated by a tri-glycyl linker. This cyclic peptide is capable of self-assembling into a network that mimics an extracellular matrix, promoting cell growth while resisting biofilm formation. He has 1 patent to his name.
Career Highlights
Maxim Ryadnov is associated with Npl Management Limited, where he continues to advance his research and development in peptide technology. His work has garnered attention for its potential applications in various biomedical fields.
Collaborations
Maxim has collaborated with notable colleagues, including Nilofar Faruqui and Angelo Bella, to further enhance the impact of his research.
Conclusion
Maxim Ryadnov's innovative work in cyclic peptide technology showcases his commitment to advancing scientific knowledge and practical applications in the field. His contributions are paving the way for future developments in cell growth and biofilm resistance.